Based on previous findings that demonstrate the elevation of MAOB activity within reactive astrocytes as the key pathological mediator of AD, understanding the underlying mechanism of how MAOB activity increases within the context of AD pathology has become crucial. The gene discussed is MAOB; the disease is Alzheimer disease.